The GLINT project has triggered major advances in CEST-pH imaging, which can prove an important monitoring tool for early response and efficacy of cancer metabolic targeting drugs.
The presentations of the GLINT researchers during the Olea Medical CEST Imaging Symposium at ISMRM 2019 are now openly available online. Watch the videos to learn about the latest GLINT results!
On May 14, 2019, the latest results of the GLINT project will be presented at the the Olea Medical symposium on CEST Imaging during the ISMRM Annual Meeting in Montreal, CA.
The GLINT Project has successfully concluded its second reporting period. Read up ton the work performed from the beginning of the project to the end of the second period.
GLINT resarch formed part of the Annual Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, October 19-21, 2017, Barcelona, ES.